CRNX Form 144: 9,911 shares sold for $370K

CRNX files a Form 144 disclosing proposed resale transactions of its Common Stock.

Rhea-AI Filing Summary

CRNX files a Form 144 disclosing proposed resale transactions of its Common Stock. The notice lists a reported sale of $370,411.47 for 9,911 shares on 03/16/2026. The filing also itemizes securities related to exercise of stock options (78,434 shares, 04/08/2026), an Employee Stock Purchase Plan entry (438 shares, 05/20/2025), and Restricted Stock Units (6,291 shares, 03/15/2024).

The Form 144 is a notice of proposed sale by an affiliate and describes the method of sale as cash transactions. It reports the broker/dealer and issuer entries tied to each lot; the filing does not state additional proceeds disposition or timing beyond the listed dates.

Insights

Securities Attorney

Form 144 documents a planned affiliate resale, reporting a specific past sale and multiple issuable lots.

The filing lists a completed sale of $370,411.47 for 9,911 common shares on 03/16/2026 and shows additional lots tied to option exercises, an ESPP, and RSUs with explicit dates. A Form 144 is procedural: it notifies the market of intended resale under Rule 144 and triggers broker/dealer processing, not an issuer issuance.

Cash‑flow treatment and final sale mechanics beyond the dates provided are not detailed in the excerpt; subsequent trade reports or Form 4/transaction confirmations would show execution specifics.

Key Figures

Sold shares reported: 9,911 shares Proceeds reported: $370,411.47 Option exercise lot: 78,434 shares +2 more

5 metrics

Sold shares reported 9,911 shares sale reported on 03/16/2026

Proceeds reported $370,411.47 amount tied to the 9,911-share sale on 03/16/2026

Option exercise lot 78,434 shares Exercise of Stock Options dated 04/08/2026

ESPP lot 438 shares Employee Stock Purchase Plan dated 05/20/2025

RSU lot 6,291 shares Restricted Stock Units dated 03/15/2024

Key Terms

Form 144, Restricted Stock Units, Employee Stock Purchase Plan, Exercise of Stock Options

4 terms

Form 144 regulatory

"Disclosing proposed resale transactions and broker entries"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Units financial

"Restricted Stock Units | Issuer | 6291 | 03/15/2024"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Employee Stock Purchase Plan financial

"Employee Stock Purchase Plan | Issuer | 438 | 05/20/2025"

An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

Exercise of Stock Options financial

"Exercise of Stock Options | Issuer | 78434 | 04/08/2026"

FAQ

What does CRNX's Form 144 disclose about insider selling?

It discloses a reported sale of 9,911 shares for $370,411.47 on 03/16/2026. The notice also lists additional lots from option exercise, an ESPP, and RSU entries with their respective dates.

Who is the reported seller in the CRNX Form 144?

The filing names Jeff Knight with an address in San Diego as the reporting person. The Form 144 lists his sale of 9,911 shares on 03/16/2026 and related issuer entries.

Does CRNX's Form 144 state how sale proceeds will be used?

No. The excerpt lists transaction amounts, dates, and securities types but does not state the use or recipient of proceeds beyond the cash sale reporting for the listed transactions.

Which types of securities are listed in the CRNX Form 144?

The notice lists Common stock connected to an Exercise of Stock Options (78,434 shares, 04/08/2026), an Employee Stock Purchase Plan (438 shares, 05/20/2025), and Restricted Stock Units (6,291 shares, 03/15/2024), plus the sold lot.

Does the Form 144 confirm the exact timing of future sales?

It lists dates tied to each lot (e.g., 04/08/2026 for an option exercise) but does not provide execution schedules or broker sale timings beyond the reported sale date of 03/16/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/08/2026 - 04:49 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001881007
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CRINETICS PHARMACEUTICALS INC
SEC File Number	001-38583
Address of Issuer	6055 Lusk Boulevard San Diego CALIFORNIA 92121
Phone	8584506464
Name of Person for Whose Account the Securities are To Be Sold	JEFF KNIGHT
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	85163	3271110.83	104705330	04/08/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/08/2026	Exercise of Stock Options	Issuer			78434	04/08/2026	Cash
Common	05/20/2025	Employee Stock Purchase Plan	Issuer			438	05/20/2025	Cash
Common	03/15/2024	Restricted Stock Units	Issuer			6291	03/15/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JEFF KNIGHT 6055 Lusk Boulevard San Diego CA 92121	Common	03/16/2026	9911	370411.47

144: Remarks and Signature

Remarks	The securities to be sold were or will be acquired upon the vesting of restricted stock units during the period of 3/15/2024 through 3/15/2026
Date of Notice	04/08/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jeff Knight
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)